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THE AMYLOID BETA DIMER/TRIMER: A POTENT STIMULATOR OF 
NEURONAL AMYLOID BETA SECRETION  
AND COFILIN-ACTIN ROD FORMATION 
 
Amyloid beta (Aβ) peptides, a heterogeneous mixture of 39-43 amino acid 
peptides produced from β- and γ-secretase cleavage of the amyloid precursor 
protein (APP), are one of the causative agents of Alzheimer disease (AD). 
Although sensitive enzyme-linked immunosorbent assays (ELISAs) for specific 
rodent Aβ peptides and for total and specific human Aβ peptides have been 
commercially available, no commercial assay for total rodent Aβ was available 
when we began these studies.  Such an assay is desirable to determine the 
effects of the human Aβ peptides on production of Aβ from cultured rodent 
neurons, the major model system used in AD research. Here we report an ELISA 
for total rodent Aβ and show that it can be used without interference from 
physiologically relevant concentrations of human Aβ. We then apply the assay to 
measure the production of Aβ in cultured dissociated rat cortical neurons and rat 
and mouse hippocampal organotypic slices in response to oxidative stress or 
treatment with human Aβ dimer/trimer (Aβd/t) obtained from culture medium of 
Chinese hamster ovary cell line 7PA2 expressing a mutant form of human 
 
 iii 
amyloid precursor protein.  Neither of the treatments leads to accumulation of 
intracellular Aβ peptides.  Peroxide increases Aβ secretion by about 2 fold, 
similar to results from previous reports that used an immunoprecipitation and 
western blot assay.  Of greater significance is that physiologically relevant 
concentrations (250 pM) of human Aβd/t increase rodent Aβ secretion by >3 fold 
over 4 days, providing support for an Aβ-mediated feed-forward model of AD 
progression. The over two fold increase in rodent Aβ secreted in response to 
human Aβd/t was nearly identical between organotypic hippocampal slices of 
TAU knock-out mice and TAU knock-out mice expressing the human tau 
transgene, demonstrating that tau plays no role in the enhanced production of 
Aβ. 
Previous studies showed oligomers of synthetic amyloid beta (Aβ1-42) 
induced cofilin activation and formation of cofilin-actin rods in a neuronal 
subpopulation of rat hippocampus primarily localized within the dentate gyrus.  
Here we demonstrate that Aβd/t at ~250 pM is more potent in rod induction in 
both dissociated hippocampal neuronal cultures and organotypic slices than is 1 
µM synthetic Aβ as typically prepared oligomers, about a 4000 fold difference.  
Treatment of the Aβd/t fraction with an Aβ-neutralizing antibody eliminates its rod 
inducing activity.  Traditionally prepared synthetic Aβ oligomers contain SDS-
stable trimers and tetramers, but are devoid of dimers.  When synthetic human 
Aβ was incubated under conditions that generate a tyrosine oxidized dimer, the 
concentration that was required to induce rods decreased dramatically.  The 
oxidized dimer had a maximum rod-inducing activity at ~2 nM (10 ng/mL), 
 
iv 
suggesting it is the presence of the SDS-stable tyrosine oxidized Aβ dimer in a 
low-n state that is largely responsible for the potency of the secreted Aβd/t. 
  Aβd/t-induced rods are highly localized to the dentate gyrus and mossy 
fiber pathway and form more rapidly (significant over controls by 2 h compared to 
8 h for those induced by synthetic Aβ-oligomers).  Aβd/t-induced rods are 
reversible, disappearing by 24 h after washout.  Cofilin dephosphorylation in 
response to Aβd/t is greatest within the hippocampal regions of rod formation.  
Overexpression of cofilin phosphatases slingshot and chronophin increase rod 
formation when expressed alone and exacerbate rod formation when coupled 
with Aβd/t treatment both in dissociated neurons and organotypic slice cultures.  
Overexpression of the cofilin kinase, LIM kinase 1, inhibits Aβd/t-induced rod 
formation.  Together these data support a mechanism through which Aβd/t 
produces selective synaptic dysfunction affecting learning and memory at least in 
part via primary effects on cofilin regulation and rod formation in sensitive 
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β-AMYLOID-INDUCED β-AMYLOID SECRETION:  
A FEED-FORWARD MODEL FOR ALZHEIMER DISEASE. 
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Abstract 
 Amyloid beta (Aβ) peptides, a heterogeneous mixture of 39-43 amino acid 
peptides produced from β- and γ-secretase cleavage of the amyloid precursor 
protein (APP), are one of the causative agents of Alzheimer disease (AD). 
Although sensitive enzyme-linked immunosorbent assays (ELISAs) for specific 




commercially available, no commercial assay for total rodent Aβ was available 
when we began these studies.  Such an assay is desirable to determine the 
effects of the human Aβ peptides on production of Aβ from cultured rodent 
neurons, the major model system used in AD research. Here we report an ELISA 
for total rodent Aβ and show that it can be used without interference from 
physiologically relevant concentrations of human Aβ. We then apply the assay to 
measure the production of Aβ in cultured dissociated rat cortical neurons and rat 
and mouse hippocampal organotypic slices in response to oxidative stress or 
treatment with human Aβ dimer/trimer (Aβd/t).  Neither of the treatments leads to 
accumulation of intracellular Aβ peptides.  Peroxide increases Aβ secretion by 
about 2 fold, similar to results from previous reports that used an 
immunoprecipitation and western blot assay.  Of greater significance is that 
physiologically relevant concentrations (250 pM) of human Aβd/t increase rodent 
Aβ secretion by >3 fold over 4 days, providing support for an Aβ-mediated feed-
forward model of AD progression. The over two fold increase in rodent Aβ 
secreted in response to human Aβd/t was identical between organotypic 
hippocampal slices of TAU knock-out mice and TAU knock-out mice expressing 
the human tau transgene, demonstrating that tau plays no role in the enhanced 
production of Aβ. 
 
Introduction 
Alzheimer disease is the major form of dementia that affects the aged with 




beyond (Alzheimer’s Association, 2010). The pathological hallmarks of the 
disease are extracellular amyloid plaques, composed primarily of the amyloid 
beta peptide, and hyperphosphorylated tau inclusions in the form of striated 
neuropil threads and neurofibrillary tangles (Bamburg & Bloom, 2009).  Familial 
AD, representing 1% or less of AD cases, arises from mutations in genes 
affecting the production or clearance in the brain of the 38-43 amino acid amyloid 
beta (Aβ) peptides (Tanzi & Bertram, 2005), which are excised from the 
transmembrane amyloid precursor protein (APP) through the actions of β- and γ-
secretases (Glenner & Wong, 1984; Price et al., 1995; Hardy & Selkoe, 2002; 
Mattson, 2004).  However, Aβ peptides also accumulate in the other 99% of AD 
cases, called sporadic AD, although the mechanisms driving its production are 
unclear (Mattson, 2004; Tanzi & Bertram, 2005).   
 Different isoforms and different conformations or aggregation states of the 
Aβ peptides deliver different signals to neurons and have remarkably different 
neuronal and synapto-toxicities. The Aβ1-42 peptides are more amyloidogenic 
than the Aβ1-40 peptides, and are more correlated with AD and its progression 
(Finder & Glockshuber, 2007; Portelius et al., 2010).  Fibrillar forms of the Aβ 
species are less toxic than the soluble oligomeric forms (Krafft & Klein, 2010).  
An oligomeric fraction, called Aβ-derived diffusible ligands (ADDLs), has effects 
on synapses at submicromolar concentrations (Krafft & Klein, 2010). However, 
an even more active form of Aβ with maximal activity at subnanomolar 
concentrations, is secreted from a cultured cell line (7PA2 cells) expressing a 




stable human Aβ (HAβ) dimers and trimers (HAβd/t), which can be isolated by 
gel filtration; the isolated HAβd/t has a marked effect on synaptic function, both in 
cultured slices and when injected into rodent brain (Cleary et al., 2005; 
Townsend et al., 2006; Shankar et al., 2007; Freir et al., 2010).  An SDS-stable 
HAβ dimer has been extracted from postmortem human AD brain and is also 
active at subnanomolar concentrations (Shankar et al. 2008). The presence of 
the SDS-stable HAβ dimer is strongly correlated with AD type dementia 
(McDonald et al., 2010). Excessive production of HAβ from APP occurs in familial 
AD due to mutations in APP and its processing enzymes or in proteins that 
normally clear the excess HAβ, but the causative factors leading to excess HAβ 
production in sporadic AD are much less understood.  HAβ is known to inhibit 
axonal transport of mitochondria and vesicles containing neurotrophin receptors 
in mouse hippocampal neurons within 60 min of treatment (Vossel et al., 2010). 
The transport inhibition is dependent on the presence of the microtubule-binding 
and stabilizing protein tau. It has been proposed that stalled vesicles containing 
APP might be the sites for enhanced production of HAβ (Maloney et al., 2005), 
since up to 70% of the Aβ secreted from cells arises from β- and γ-secretase 
cleavage of APP within the lipid raft environment of endosomes (Koo & Squazzo, 
1994; Ehehalt et al., 2003; Thomas et al., 2006; Cirrito et al., 2008).  Although 
ELISAs have been available for quantifying individually either Aβ1-40 or Aβ1-42 
from rodents or humans (Fukumoto et al., 1999; Gasparini et al., 2004; Covance 
BetaMark x-40 SIG-38950, x-42 SIG-38952), no single ELISA for total rodent Aβ 




development of an ELISA for total RAβ using the sandwich method requiring two 
primary antibodies. The capture antibody is on the ELISA plate, and is specific 
for RAβ.  The detection antibody binds to both RAβ and HAβ in solution and has 
a detection probe (HRP) attached. We then demonstrate that this assay can be 
used in the presence of physiologically relevant amounts of HAβd/t and apply the 
assay to cultures of rat cortical neurons and rat and mouse organotypic 
hippocampal slices treated with HAβd/t and with peroxide, another neuronal 
stress agent previously shown to increase Aβ secretion.  
 
Materials and Methods 
Reagents 
 Unless otherwise noted, all chemicals are reagent grade and were 
obtained from Sigma-Aldrich Co. (St. Louis, MO), and all tissue culture reagents 
were obtained from Life Technologies (Carlsbad, CA).  Synthetic human amyloid 
beta (HAβ1-42) was obtained from AnaSpec, Inc. (San Jose, CA), and synthetic 
rodent amyloid beta (RAβ1-42 and RAβ1-40) was a gift from Covance (Princeton, 
NJ).  The HAβ monomer (HAβm) and dimer/trimer (HAβd/t) fractions were 
prepared from the conditioned medium from Chinese hamster ovary (CHO) cells, 
clone 7PA2, expressing a mutant human APP (Walsh et al., 2002; a gift from 
Dennis Selkoe, Harvard Medical School), fractionated by size-exclusion 
chromatography as previously described (Townsend et al., 2007). Unless 
otherwise noted, it was used at the equivalent of 1x concentration (250 pM, the 




type CHO cells was fractionated identically by size-exclusion, and fractions at the 
equivalent elution positions of HAβd/t were used as one control. 
 
Dot-blot assay for quantifying Aβ in 7PA2 cell medium 
 HAβ was quantified in 7PA2 cell culture medium using dot blots with 
synthetic human β-amyloid peptide (HAβ1-42) as a standard as previously 
described (Davis et al., submitted). Briefly, samples were applied to nitrocellulose 
(0.1 μm), the membrane was boiled 10 min in PBS, and HAβ was detected with 
6E10 antibody (overnight at 4oC) followed by a goat-anti-mouse antibody 
conjugated to DyLight 680 (1:15,000 for 45 min; Thermo Scientific, Rockford, IL). 
Spots were imaged with a LI-COR Odyssey Infrared Imaging System, and 
intensities quantified using TotalLab software (Nonlinear Dynamics, Newcastle 
upon Tyne, UK).  
 
Sandwich ELISA 
 Synthetic RAβ1-40 and RAβ1-42 were solubilized to 1 mg/mL in 0.1% 
ammonium hydroxide.  Aliquots (10μL) were dried in a speed-vac and pellets 
were stored at -80°C.  Costar 96-well white solid plates coated with 100 μL of 
either 2, 5, or 10 μg/mL of capture antibody, a rabbit polyclonal raised against 
amino acids 1-16 of RAβ, were provided by Covance (SIG-39153).  The 
detection antibody is a horseradish peroxidase-conjugated mouse monoclonal, 
(SIG-39245; Covance) that is reactive to both HAβ and RAβ.  Synthetic RAβ1-40 




phosphate buffered saline containing Tween and BSA (PBSTB; Covance).    
Wells to be used on the assay plate were washed 1x with PBSTB and standards 
or samples (100 μL per well) were applied and plates incubated overnight at 4°C.  
Wells were washed 5x with 300 μL PBSTB.  SuperSignal ELISA Pico 
Chemiluminescent Substrate (Thermo Scientific) was added at 300 μL to each 
well.  Chemiluminescence was quantified by photon counting between 5 and 10 
minutes using a Perkin-Elmer Victor V multi-mode microplate reader operating at 
room temperature with no filter. 
 
Human Aβ interference in rodent Aβ ELISA: 
HAβ1-42 (AnaSpec) was solubilized with 1,1,1,3,3,3-Hexafluoro-2-propanol 
to 1 mg/mL.  Aliquots (10 μL) were allowed to air dry at room temperature and 
pellets were frozen at -80°C.  Pellets were solubilized with 10 μL of DMSO, and 
diluted with Neurobasal containing B27 supplement to their desired 
concentration.  In one set of experiments RAβ1-42 was maintained at 150 pg/mL 
and the amount of HAβ1-42 was varied from 10 pg/mL to 1 μg/mL.  In a second 
set of experiments HAβ1-42 was maintained at 1.9 ng/mL (about the highest 
concentration of HAβd/t used in cell treatments) and RAβ was varied. Tubes 
containing mixed HAβ and RAβ were placed at 37°C for 72 hrs to mimic any co-
oligomerization between human and rodent Aβ that might occur during the three 
days in which rodent cells are exposed to HAβ.  Detection antibody at a final 




min, samples were added to sandwich ELISA plates and processed as described 
for Sandwich ELISA. 
 
DNA Assay  
 Calf Thymus DNA was solubilized with 100 mM Tris, 10 mM EDTA, pH 8.0 
(TE buffer) and its final concentration determined spectrophotmetrically using an 
extinction coefficient of .02 μg/mL-1⋅cm-1 at 260nm.  Cells grown in Lab-Tek 8 well 
chamber slides were lysed with 200 μL of DNA lysis buffer (25 mM NaOH, 10 
mM EDTA, pH 12.0), and wells were washed 2x with 300 μL of TE buffer which 
was added to the lysate.  Standards and samples were diluted with TE buffer 
containing 1:10,000 SybrGreen I (Life Technologies, Carlsbad, CA).  Lysates 
from the dissociated neuronal cell cultures were diluted 1:50 in TE buffer 
containing SybrGreen I. Organotypic mouse hippocampal slices were removed 
from the coverslip and lysed in 200 μL of DNA lysis buffer for 30 min at room 
temperature and 600 μL of TE buffer was added to lower the pH.  Slice lysates 
were further diluted 1:200 in TE buffer with SybrGreen I. Samples and standards 
were added at 100 μL per well onto 96-well white solid plates (Costar, Corning 
Inc.).  Fluorescence was quantified for 0.1 s per well on a Perkin-Elmer Victor V 
multi-mode microplate reader equipped with fluorescein filters.  
 To determine if all DNA was released from cells during lysis, slides were 
mounted with ProLong Gold Antifade reagent supplemented with 1:10,000 
SybrGreen I to visualize any remaining dsDNA using a Nikon Diaphot equipped 




CoolSNAP cf CCD camera.  Fluorescence intensity was measured across entire 
images using MetaMorph v7.03 (MDS Analytical Technologies, Toronto, 
Canada). Wells containing no cells were used as negative controls. 
 
Neuronal cell culture 
Animal studies were performed according to The National Research 
Council’s guide for the care and use of laboratory animals using protocols 
approved by the Institutional Animal Care and Use Committee.  E18 rat cortical 
and hippocampal neurons were obtained from timed-pregnant dams purchased 
from Harlan (Indianapolis, IN) and were prepared as previously described 
(Minamide et al., 2000). After counting, 300,000 cells were plated per well onto 8 
well chamber slides (Lab-Tek, Thermo Scientific, Portsmouth, NH) that had been 
coated with poly-D-lysine.  Neurons were cultured in 400 μL of Neurobasal 
medium supplemented with 1x B27, 2 mM GlutaMAX, and 100 μg/mL 
Penicillin/Streptomycin.   
Mouse N2a neuroblastoma cells were obtained from ATCC and cultured in 
Dubelco’s Modified Eagle Medium (D-MEM) with 4.5 g/L D-glucose, 2 mM L-
glutamine, 110 mg/L sodium pyruvate, and 10% fetal bovine serum.  Cells were 
plated at 5,000 cells per well onto 8 well chamber slides.  One day after plating, 
cells were stressed with varying concentrations of hydrogen peroxide.  After 3 
days the medium was collected and diluted 1:10 with PBSTB and processed 




To determine the amount of internal RAβ within cortical neurons we 
cultured neurons identically as if media were to be assayed for RAβ content.  
After cells were stressed for 3 days we removed the media, and washed the cells 
with PBS.  Cells were lysed in PBSTB containing 0.1% NP-40 for 5 min at room 
temperature and the lysate was processed identically to the medium using the 
RAβ ELISA.    
 
Organotypic hippocampal slice cultures 
Hippocampal slices (400 μm thick) were prepared from P6 Sprague 
Dawley rat pups (Stoppini et al., 1991) and cultured on membranes in 6 well 
dishes as previously described (Davis et al., 2009).  Hippocampal slices (300 μm 
thick) on glass coverslips were prepared from P7 mouse pups (TAU-/- (B6.Cg-
Mapttm1(EGFP)Klt, Jackson Labs, Bar Harbor, ME) and TAU-/- mice carrying the 
human tau transgene (B6.Cg- Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J).  Washed 
coverslips (12x22mm) were treated with 2% 3-aminopropyltriethoxysilane in 
acetone (10 sec dip), rinsed, air dried and UV sterilized.  Chick plasma (4 μL) 
was spread into a 5 mm diameter circle near one end of the cover slip, two slices 
were placed side by side on the plasma and the slices were covered with 8 μL of 
fresh plasma/thrombin mixture (20 μL chick plasma (Cocalico Biologicals Inc., 
Reamstown, PA) and 6 μL thrombin (150 NIH units/ml in water; MP Biomedicals, 
Inc.).  After the plasma clotted, the coverslip was inserted into a flat sided tube 
(Nunclon Delta Tubes, Nalge Nunc, Rochester, NY) and 600 μL slice culture 




revolutions per hour) at 35oC.  The original slice medium (per 205 mL: 50 mL 
horse serum, 50 mL Hanks BSS, 4 mL 25% glucose, 100 mL minimum essential 
medium containing glutamax (250 μL/100 mL), HEPES (4.76g/ L) and Pen/Strep 
(1 mL)) was replaced on day 2 with Neurobasal A medium containing (per 50 
mL): 48 mL Neurobasal A, 180 μL 25% glucose, 625 μL Glutamax 1, 1 mL B27 
supplements and 250 μL Pen/Strep.  The Neurobasal A medium was replaced 
every 2-3 days. Slices were allowed to recover for at least 1 week after 
dissection before treatment. 
 
Statistics 
All experiments were performed a minimum of two times with at least 
triplicate samples for every point but only a single experiment is shown.  Error 
bars on each plot are standard deviations across at least 3 samples, and p 
values were determined from paired two-tail t tests. 
 
Results 
Development of an ELISA for total rodent Aβ 
 Several ELISAs have been reported that measure a variety of Aβ species 
or conformations including assays for RAβ1-40 or RAβ1-42 (Fukumoto et al., 1999; 
Walsh et al., 2000; Stenh et al., 2005; Xia et al., 2009).  However, no commercial 
ELISA was available for measuring total RAβ.  Such an assay could be used to 
quantify the effects of various stress agents on Aβ secretion from cultured 




independently.   Covance, a company that manufactured ELISA plates for 
assaying either RAβ1-40 or RAβ1-42, agreed to supply us with plates and reagents 
to optimize a total RAβ ELISA.  We developed a sandwich ELISA in which an 
antibody specific to total RAβ is bound to the plate (capture antibody) and a 
horseradish peroxidase (HRP) conjugated detection antibody, directed against 
an epitope well separated from the capture antibody, is preincubated with the 
sample. To determine the optimal concentration of capture antibody that allowed 
for maximal binding of RAβ to the plate, we coated plates with varying 
concentrations (2, 5, 10 μg/mL) of capture antibody.  Synthetic RAβ1-40 and RAβ1-
42 were diluted (0-600 pg/mL), the HRP-conjugated detection antibody (1.6 
μg/mL) was added and after 10 min the samples were placed in wells of the 96 
well plate.  Plates coated with 5 or 10 μg/mL capture antibody gave identical 
curves that were linear between 10-600 pg/mL Aβ and both RAβ1-40 and RAβ1-42 
were recognized with equal affinity (Figure 1.1).  The plate coated with 2 μg/mL 
of capture antibody became saturated above 400 μg/mL using either Aβ species 
(data not shown).  Thus, all reported assays were performed on plates coated 
with 5 or 10 μg/mL capture antibody. 
 
Determining the maximum level of HAβ that does not interfere in RAβ ELISA 
 Rodent and human Aβ peptides differ in sequence in only three residues 
(Arg5, Tyr10, and His13 in HAβ is replaced by Gly5, Phe10, and Arg13 in RAβ) 
that are all within the epitope recognized by the capture antibody. By inference 











Figure 1.1. RAβ ELISA standard curves comparing RAβ1-40 and RAβ1-42. There is 
no significant difference between the two RAβ species in this assay. The assay is 
linear between 10 pg/mL and 600 pg/mL. Points are triplicate samples; error bars 











interference by Aβ from non-rodent species.  To be able to utilize the RAβ ELISA 
in the presence of HAβ, the maximum level of HAβ that could be tolerated in the 
assay needed to be determined.  A constant level (150 pg/mL) of RAβ1-42 was 
maintained in the assay while HAβ1-42 was added from 10 pg/mL to 1 μg/mL 
(Figure 1.2A).  HAβ1-42 at 5 ng/mL or less had no effect on the ability of the 
ELISA to correctly quantify the RAβ.  The increased signal obtained at higher 
concentrations of HAβ could arise either from some weak affinity of the capture 
antibody for the HAβ or from co-oligomerization between RAβ and HAβ that 
might occur at higher Aβ concentrations (Fung et al., 2004; Jankowsky et al., 
2007). 
 We also performed the RAβ ELISA using a constant amount of HAβ (1.9 
ng/mL, approximately the maximum concentration in the HAβd/t fraction) with 
increasing concentrations of RAβ (from 10 pg/mL to 1μg/mL).  At concentrations 
of RAβ below 600 pg/mL, the presence of the HAβ had no effect on the standard 
curve, demonstrating the ELISA is specific for RAβ within its linear region (Figure 
1.2B).  
 
Measurement of secreted RAβ from a rodent cell line 
  It was previously reported that peroxide induced secretion of Aβ from 
human neuroblastoma SH-SY5Y cells through JNK-dependent activation of γ-
secretase (Shen et al., 2008).  Therefore, we first utilized a mouse 
neuroblastoma cell line (N2a) to apply the RAβ ELISA.  Mouse N2a cells were 






Figure 1.2. Effects of HAβ on the RAβ ELISA. (A) Effects of variable amounts of 
HAβ1-42 on the ability of the ELISA to detect a fixed amount (150 pg/ml) of RAβ1-
42. Samples were incubated at 37°C to allow possible co-oligomerization to occur 
before the addition of detection antibody.  Points are averages of triplicate 
samples; error bars = standard deviation (less than size of symbol for 
concentrations below 10 ng/mL).  (B)  Effects of a fixed amount of HAβ1-42 (1.9 
ng/ml) on the RAβ ELISA standard curve.   Samples of each concentration were 
incubated at 37°C for 3 days before assay to mimic the incubation conditions for 
secreted RAβ in the presence of the HAβd/t.  Points are averages of triplicate 








































hydrogen peroxide (0.5 mM to 10 mM) for 3 days.  Medium was harvested and 
assayed for RAβ in triplicate wells.  There was a significant increase (p≤0.05) in 
secreted RAβ levels for peroxide concentrations above 0.5 mM when compared 
to untreated controls with a maximum of over 5 fold obtained when treating with 2 
mM peroxide (Figure 1.3).   However, it was obvious from phase microscopy 
observation of the wells that significant cell loss occurred, especially at peroxide 
concentrations above 2 mM.  
To normalize Aβ secretion to cell number we applied an assay to measure 
DNA levels in cultured cells, using the DNA binding dye SybrGreen I, which does 
not react with nucleotides, RNA, single-stranded nucleic acids, and proteins, as 
may occur with other DNA binding dyes (Kricka, 2002).   DNA standard curves 
generated from calf thymus DNA were linear between 1-300 ng/mL (Figure 1.4).  
To normalize the Aβ secreted by the peroxide treated N2a cells to cell number, 
medium was removed from each well and analyzed for total RAβ and the 
remaining cells were lysed, the lysates diluted, and the DNA quantified.  When 
normalized for secreted RAβ on a per cell basis, secretion of RAβ increased with 
increasing peroxide up to a maximum at 2 mM  (Figure 1.3).  
 
Application of the RAβ ELISA to primary neurons 
Primary E18 rat cortical neurons were cultured in 8 well chamber slides for 
3 days, and were left untreated or treated with varying concentrations of 
peroxide. Three days later culture medium was removed and assayed for RAβ. 








Figure 1.3.  N2a cells were treated with different concentrations of hydrogen 
peroxide and the total RAβ secreted was determined after 3 days and normalized 
to levels secreted from untreated cells. An apparent decline in secreted Aβ 
occurred at peroxide concentrations above 2 mM.  However, after correcting for 
cell loss by normalizing secreted Aβ to DNA in each well, the production of Aβ 
reached a plateau at or above 2 mM peroxide. * values of p ≤ 0.05 compared to 
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Figure 1.4. Standard curves for DNA using calf thymus DNA dissolved in TE as 
the standard.  Standards and cell lysates are diluted with TE and SybrGreen I 
and then assayed using a microtiterplate reader operating in the fluorescence 
mode.    The assay is linear between 1 ng to 300 ng/mL of DNA, but linearity can 
be expanded by adjusting the intensity of fluorescence or exposure time.  Points 



























quantify either DNA (using the DNA Lysis Buffer) or the internal pool of RAβ  
using PBSTB w/ 0.1% NP-40).  
Untreated neurons secreted 63 ± 5 pg (n=3) of Aβ per well equating to 
157.0 pg/mL over the course of three days.  By normalizing the concentration of 
Aβ to the DNA content of the well (1.72 ± .09 μg), we calculate that there are  
0.036 pg Aβ/ng of DNA (Figure 1.5A). To determine the number of molecules 
secreted by each cell one can assume that there is 6.5 pg of DNA/cell (Ausubel 
et al., 1994); therefore, over a three day period, each cell secretes 220 ag of RAβ 
(or ~29,000 molecules), which equals about 6-7 RAβ peptides per minute/neuron 
under non-stress growth conditions. 
Cortical neurons were stressed for 3 days with various concentrations (1 
μM – 10 mM) of hydrogen peroxide, media were collected and RAβ contents 
were measured and normalized to DNA (Figure 1.5A).  Concentrations of 
peroxide over 2 mM resulted in increasing cell death, observed by a decline in 
overall DNA content (data not shown). When compared to untreated neurons 
there was a significant (p≤0.05) increase in RAβ secreted only at or above 
peroxide concentrations of 100 μM, with a maximal secretion observed at 2 mM 
peroxide, resulting in a 2.4 ± 0.2 fold increase over untreated neurons (Figure 
1.5A).  This fold increase is similar to the increase (2.4 ± 0.6 fold over controls) 
observed in chick tectal neurons exposed to 10-20 μM peroxide for 20 h 
(Goldsbury et al., 2008).  It is important to note that we elected to keep the B27 
supplements in the neuronal culture medium because the supplements contain 






Figure 1.5.  Effects of peroxide on secretion of RAβ from primary cortical 
neurons.   (A) Normalized dose-response of RAβ secretion to hydrogen peroxide 
in rat E18 cortical neurons cultured in 8 well chamber slides. After 3 days of 
exposure, medium was removed from each well and cells were lysed with DNA 
lysis buffer.  Medium was analyzed to determine the concentration of secreted 
RAβ and the cell lysate was analyzed to determine the DNA content. Values 
were normalized to untreated wells. Points are averages of triplicate samples; 
error bars = standard deviation, * values with p ≤0.05 compared to untreated.  
RAβ secretion peaks with the addition of 2 mM peroxide.  (B) Time course of 
RAβ secreted from rat E18 cortical neurons in response to 2 mM peroxide 
treatment.  Medium was removed for RAβ assay and cells were lysed for DNA 
measurement at the times indicated.  Points are averages of triplicate samples, 
































































viable over the three day culture period.  Thus, much higher concentrations of 
peroxide were required in these experiments than were needed to induce 
secretion in chick tectal neurons.   
An increase in the internal pool of RAβ has been reported in neurons 
responding to certain types of stress (Hasegawa et al., 2005) and has been 
associated with synaptic dysfunction in mouse models of AD (Oddo et al., 2003; 
Casas et al., 2004). Thus, we quantified the internal pool of RAβ in lysed neurons 
untreated or treated with peroxide.  The internal RAβ was not significantly 
different between untreated and peroxide-treated neurons.  Untreated neurons 
had 4.3 ± 0.6 pg of RAβ per ng DNA and 2 mM peroxide-treated neurons 
contained 4.9 ± 0.8 pg of RAβ per ng DNA. 
We next determined the time course of RAβ production in cortical neurons 
stressed with 2 mM peroxide.  Neurons were plated identically as above and 
stressed with peroxide, with medium being collected after peroxide treatment at 
24 h intervals up to 4 days.  Although increased secretion was observed as early 
as 12 h after treatment, the increase was not statistically significant (p ≤ 0.05) 
until 50 hrs, with maximal secretion obtained at 72 hrs (Figure 1.5B).      
Because dissociated neurons might behave differently from neurons that 
maintain their connections with glia and other neurons, we also determined how 
peroxide affected the secretion of RAβ from rat hippocampal organotypic slices. 
Slices that had been grown on membranes for > 1 week (to allow recovery from 
the stress of preparation) were treated with 2 mM peroxide and after three days 




for DNA quantification.  When RAβ levels are compared to untreated slices on a 
per slice basis there is a 2.1 ± 0.3 fold increase; however when normalized to 
DNA, the fold increase is 1.5 ± 0.3, which is still significant but less than from the 
2.4 fold increase observed for dissociated cortical neurons (Figure 1.6).  Each 
untreated slice secretes 85 ± 8 pg (n=3) of RAβ over the course of 3 days. 
 
HAβ dimer/trimer induces secretion of RAβ 
 Although synthetic HAβ peptides are usually used at concentrations well 
above 10 nM (45 ng/mL) to obtain any physiological or morphological changes in 
neurons, the secreted form of HAβ containing SDS-stable dimers and trimers 
(HAβd/t) (Walsh et al., 2002) and HAβ dimers extracted from postmortem AD 
brain (Shankar et al., 2008) are active at concentrations in the pM range (Freir et 
al., 2010), well below the levels of HAβ that interfere in our rodent ELISA.  Thus 
we can for the first time directly assay the effects of physiologically relevant 
amounts of HAβ on RAβ secretion.  
The conditioned medium from 7PA2 and wild type CHO cells was 
fractionated as previously described (Townsend et al., 2007).  Fractions that 
contained primarily monomer (Aβm) and Aβd/t were obtained (Figure 1.7).  The 
amount of HAβ in each fraction was quantified using a dot blot assay, because 
after adherence of the HAβ species the membrane could be boiled to expose the 
epitopes for detection.  This step is essential for quantification of HAβ because 
oligomers are inefficiently measured by ELISA (Stenh et al., 2005), but it is not 















Figure 1.6. Comparison of effects of hydrogen peroxide (2 mM), HAβm, and 
HAβd/t on RAβ secretion from dissociated cortical neurons and organotypic 
hippocampal slices.  Media from both neuronal and slice cultures were harvested 
3 days after peroxide addition, RAβ levels were analyzed by ELISA,  normalized 
to DNA, and expressed relative to untreated wells.  Bars are average values from 
triplicate samples; error bars = standard deviation; * values with p ≤ 0.05 









































Figure 1.7. Western blot showing fractions of the HAβm and HABd/t from 10x 
concentrated culture medium of 7PA2 cells.  The elution positions of monomer, 
dimer and trimer are shown. A total of 800 µl was removed from each fraction 
and stored at –80°C. The remaining 200 µl was lyophilized, resuspended 
in 2x sample buffer, and electrophoresed on a 10–20% Tris-Tricine gel. Proteins 
were transferred onto 0.1 µm nitrocellulose and detected, after boiling the blot for 
10 min, by Western blotting for Aβ with 6E10 mouse monoclonal antibody and 
DyLight secondary antibodies detected with a Li-Cor Odyssey Infrared Imaging 
System. Fractions enriched in monomer (fractions 14-16) or dimer/trimer 
(fractions 12 and 13) were pooled separately, lyophilized, and stored at –80°C. 
They were used at the equivalent of 1x to treat cells. The amounts of HAβ in 









oligomerize at its secreted concentrations.  The HAβm and HAβd/t fractions, as 
well as their respective controls (equivalent fractions from gel filtration of wt CHO 
cell medium), were added to 3 day old cultures of rat cortical neurons.  Secreted 
rodent Aβ was quantified at 0, 24, 48, 72 and 96 h and normalized to the amount 
of DNA in each sample (Figure 1.8).  The presence of HAβ did not interfere in the 
RAβ ELISA, as previously shown in Figure 1B, and confirmed here by the lack of 
change between untreated and HAβ-treated groups at time zero (Figure 1.8).   
Neurons treated with the HAβd/t, but not monomer or fractions from control CHO 
cell medium, induced secretion of RAβ to more than a 3-fold increase over 
controls by 4 days.    Because of the possible co-oligomerization between the 
HAβd/t and the RAβ that could alter the assay results, we boiled some of the 
samples to enhance epitope exposure before performing the RAβ ELISA, but no 
differences between the boiled and unboiled samples were detected (data not 
shown).   By 96 h the amount of RAβ was nearly identical to the amount of 
human Aβd/t added, so if co-oligomerization had occurred we should have 
observed an enhanced signal after boiling.   
The effects of HAβm and HAβd/t on the secretion of RAβ from rat 
hippocampal organotypic slices was also determined.  Slices were grown 
essentially as described in the peroxide experiments, and were treated with 
HAβm or HAβd/t and harvested 3 days after insult (Figure 1.6).  When RAβ 
levels are compared to untreated slices on a per slice basis, there is no change 
in RAβ with HAβm treatment (0.9 ± 0.2 fold change), however HAβd/t treatment 










Figure 1.8. Time course of RAβ production from rat cortical neurons, untreated 
or treated with HAβm or HAβd/t fractionated from 7PA2 culture medium.  Rat 
cortical neurons grown 3 days were left untreated or were treated with gel filtered 
fractions containing HAβm (3.6 ng/mL), HAβd/t (1.1 ng/mL) or equivalent 
volumes of the same fractions from wild type CHO cell culture medium (controls).  
Medium was removed at 0, 24, 48, 72, and 96 hrs after HAβ addition, and 
analyzed for RAβ.  Cells were lysed and DNA measured for normalization.  
Values were then expressed relative to the untreated samples at time=0. All 
controls using fractionated medium from wild type CHO cells were not 
significantly different from the untreated controls of the same time point.  Bars 
are average values from triplicate samples; error bars = standard deviation; * 






































organotypic hippocampal slices are compared to cortical neurons treated with 
HAβd/t there is a similar fold increase in RAβ secretion with both types of 
neurons. 
There was no significant change in the amount of RAβ in the intracellular 
pool measured in lysates of cells treated with HAβd/t.  Normalized per ng of 
DNA, untreated neurons had 5.1 ± 0.4 pg of RAβ, cells treated with HAβm had 
4.8 ± 0.3 pg, and cells treated with HAβd/t had 5.4 ± 0.5 pg of rodent Aβ. These 
values were similar to the intracellular RAβ amounts reported above for the 
control and peroxide treated neurons (4.3 to 4.9 ± 0.8 pg). 
 To determine if the effects of HAβd/t on RAβ secretion are dependent on 
the microtubule protein tau, organotypic hippocampal slices from transgenic mice 
with either tau null (TAU-/-) or TAU-/- carrying a human tau transgene were used. 
These slices were cultured in pairs on glass coverslips in 0.6 mL of medium, 
which minimized the amount of HAβd/t required.  Slices were stressed with 2 mM 
peroxide, HAβm (at 3.6 ng/ml), or HAβd/t (1.1 ng/ml) after slices had stabilized.  
After 3 days of treatment RAβ levels were quantified and normalized to DNA 
content (Figure 1.9).  Both tau null slices and slices expressing the transgenic 
human tau showed a nearly identical increase in levels of RAβ when stressed 
with peroxide (1.6 ± 0.2 and 1.5 ± 0.2, respectively).  Slices treated with HAβm 
showed no change in RAβ levels when compared with untreated slices.  RAβ 
secreted from slices treated with HAβd/t increased 2.1 ± 0.3 fold (tau null) and a 
2.3 ± 0.3 fold (transgenic human tau).  Taken together, these results suggest that 










Figure 1.9. The presence or absence of tau has no effect on RAβ secretion 
induced by either peroxide or HAβd/t. Triplicate roller tubes containing two 
organotypic hippocampal slices from mice of genotype mouse TAU-/- or mouse 
TAU-/- with a human tau transgene were cultured for 10 or more days and then 
treated with 2 mM peroxide, HAβm (3.6 ng/mL) or HAβd/t (1.1 ng/mL). After 3 
days, medium was harvested for measurement of secreted RAβ and tissue was 
lysed to measure DNA for normalization. Bars are averages of triplicate samples, 





































 Transgenic mice expressing human mutant APP are commonly used for 
AD research, but these animals also express endogenous mouse APP, which 
limits their usefulness when trying to measure effects on APP processing and Aβ 
release since quantifying mixed species of Aβ is more complex.  In addition, HAβ 
peptides oligomerize and oligomers are not efficiently measured by a typical 
ELISA (Stenh et al., 2005), unless samples are denatured by boiling or treated 
with denaturants, both of which may decrease the accuracy of their 
determination.  Furthermore, a goal of our work is to apply an ELISA for 
measuring RAβ secreted in response to treatment of cells with HAβ oligomers, 
something that is not feasible to do in cells secreting HAβ.  Thus we developed 
an assay for total RAβ which can be used in the presence of physiologically 
relevant concentrations of HAβ oligomers.  The advantage of the use of rodent 
neurons from non-transgenic animals is several fold: (1) they are easier to obtain 
and maintain than transgenic animals (Castrop, 2010); (2) rodent neurons 
(hippocampal and cortical) are the standard model system for studying the 
behavioral effects of HAβ treatment, both electrophysiologically and 
morphologically (Wang et al., 2004; Cleary et al., 2004; Shankar et al., 2007; 
Shankar et al., 2008; Freir et al., 2010); (3) the RAβ they produce does not 
oligomerize eliminating any need for boiling or denaturing higher order 
complexes before analysis (Atwood et al., 2004; Marksteiner & Humpel, 2008); 
(4) both rat and mouse Aβ peptides have the identical sequences and either 




Chick neurons produce Aβ with sequence, isoform patterns, and 
oligomerization patterns identical to HAβ (Esselmann et al., 2004; Carrodeguas 
et al., 2005), making them a useful system for some studies, but not for 
experiments in which treatment with HAβ is desired.  Previously it was shown 
that 10-20 μM peroxide treatment causes a 2.4 fold increase in secreted Aβ after 
20 hours in chick tectal neurons using an immunoprecipitation and Western 
blotting assay (Goldsbury et al., 2008). Only monomeric Aβ was quantified 
because it was the only species to show up on the western blots, perhaps 
because SDS-stable oligomers would not be visualized without boiling the 
membrane.  In our assays, which were performed in the presence of the B27 
supplement, we obtained no effect on RAβ production until we exceeded 100 μM 
hydrogen peroxide, demonstrating the protective effect of the B27 antioxidants 
and explaining why we required using much higher levels of peroxide than in 
previous studies in which neurons were maintained for shorter time periods (less 
than 24 h) (Goldsbury et al., 2008).   
Conventional approaches to studying Aβ secretion in cultured neurons 
focus on overexpressing human APP, and measuring HAβ secreted into the 
extracellular environment (Busciglio et al., 1993; Suzuki et al., 1994).  Here we 
show that this method might cause artificially high levels of secreted HAβ, simply 
due to the fact that there is a positive feedback loop where HAβd/t secreted can 
cause a further increase in HAβ secretion.  Furthermore when using an ELISA to 
quantify the amount of HAβ secreted, low values are often observed because 




2005); however RAβ does not oligomerize making it easier to get accurate values 
on its secreted level.  When using the ELISA to look at HAβ-induced RAβ 
secretion it is necessary to use the highly active naturally secreted Aβ dimer 
containing fractions (either from AD brain or 7PA2 conditioned medium) since 
synthetic HAβ is required at concentrations well above those that interfere with 
the RAβ ELISA. 
HAβm does not show any synaptic detrimental effects and it has a role in 
neuroprotection, perhaps acting as a scavenger for metal induced oxidative 
stress (Zou et al., 2002).   Here we show that HAβm does not cause an increase 
in RAβ secretion providing additional support that HAβm is not a pathogenic 
species responsible for AD (Giuffrida et al., 2009).  Recently other small Aβ 
oligomers, specifically the dimer and the trimer, have been  proposed as the 
species responsible for AD, and the synaptic deficits associated with the disease 
(Walsh et al., 2002; Cleary et al., 2004; Shankar et al., 2008; Freir et al., 2010).  
The dimer is found in AD brain but not in brains of stroke patients or patients 
diagnosed with diseases unrelated to HAβ overproduction (Shankar et al., 2008), 
and the dimer is correlated with severity of AD dementia (McDonald et al., 2010).  
Furthermore, synthetic HAβ does not form dimers when the oligomers are 
prepared under traditional incubations conditions (Dahlgren et al., 2002; Stine et 
al., 2003) and these oligomers are at least 100-200 fold less potent than naturally 
secreted HAβ at decreasing long-term potentiation (Wang et al., 2004).   
HAβ rapidly inhibits fast axonal transport, however in tau null neurons 




that HAβ requires tau for its effects on vesicle transport.  Between 40 and 70% of 
the Aβ secreted by neurons is produced following endocytosis of APP (Cirrito et 
al., 2008).  Following endocytosis much of the APP and vesicular Aβ is trafficked 
to lysosomes and digested after endosome-lysosome fusion (Lorenzen et al., 
2010). It has been previously suggested that inhibition of vesicle transport may 
be one means to generate enhanced Aβ production (Maloney et al., 2005). Thus, 
we determined if tau-dependent blockage is required to get enhanced RAβ 
secretion by comparing the levels of secreted RAβ from HAβd/t-treated 
organotypic hippocampal slices obtained from TAU-/- mice and TAU-/- mice 
expressing a human tau transgene.  We found no significant differences in RAβ 
secreted in response to HAβd/t from organotypic slices from either mouse, 
suggesting that tau-dependent transport inhibition per se plays no significant role 
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AMYLOID BETA DIMERS/TRIMERS POTENTLY INDUCE COFILIN-ACTIN 
RODS THAT ARE INHIBITED BY MAINTAINING COFILIN 
PHOSPHORYLATION 
 
Preface and Acknowledgement 
 The work presented in this chapter was submitted to Molecular 
Neurodegeneration.  The order and list of authors is as follows: Richard C. Davis, 
Ian T. Marsden, Michael T. Maloney, Laurie S. Minamide, Marcia Podlisny,  
Dennis J. Selkoe, and J.R. Bamburg.  My contributions to the work include: (1) 
the purification of the Aβ monomer and dimer/trimer from 7PA2 conditioned 
medium; (2) the quantification of the Aβ secreted by these cells using a dot-blot 
assay; (3) purification and testing of the dityrosine cross-linked synthetic human 
Aβ1-42 dimer.    
The authors gratefully acknowledge funding from the NIH National 
Institute of Neurological Disorders and Stroke (NS40371 to J.R.B., NS43115 to 
RCD, MTM, and JRB) and a Core Infrastructure Grant for Microscope Imaging 
from Colorado State University.  We are grateful for technical assistance of Chi 
Pak and Alisa Shaw and valuable discussions from these same individuals and 





 Previously we showed oligomers of synthetic amyloid beta (Aβ1-42) 
induced cofilin activation and formation of cofilin-actin rods in a neuronal 
subpopulation of rat hippocampus primarily localized within the dentate gyrus.  
Here we demonstrate that CHO cell (7PA2) secreted Aβ dimer/trimer (Aβd/t) at 
~250 pM is more potent in rod induction in both dissociated hippocampal 
neuronal cultures and organotypic slices than 1 µM synthetic Aβ as typically 
prepared oligomers, about a 4000 fold difference.  Treatment of the Aβd/t fraction 
with an Aβ-neutralizing antibody eliminates its rod inducing activity.  Traditionally 
prepared synthetic Aβ oligomers contain SDS-stable trimers and tetramers, but 
are devoid of dimers.  When synthetic human Aβ was incubated under conditions 
that generate a tyrosine oxidized dimer, the concentration that was required to 
induce rods decreased dramatically.  The oxidized dimer had a maximum rod-
inducing activity at ~2 nM (10 ng/mL), suggesting it is the presence of the SDS-
stable tyrosine oxidized Aβ dimer in a low-n state that is largely responsible for 
the potency of the secreted Aβd/t.  Aβd/t-induced rods are highly localized to the 
dentate gyrus and mossy fiber pathway and form more rapidly (significant over 
controls by 2 h compared to 8 h for those induced by synthetic Aβ-oligomers).  
Aβd/t-induced rods are reversible, disappearing by 24 h after washout.  Cofilin 
dephosphorylation in response to Aβd/t is greatest within the hippocampal 
regions of rod formation.  Overexpression of cofilin phosphatases slingshot and 
chronophin increase rod formation when expressed alone and exacerbate rod 




organotypic slice cultures.  Overexpression of the cofilin kinase, LIM kinase 1, 
inhibits Aβd/t-induced rod formation.  Together these data support a mechanism 
through which Aβd/t produces selective synaptic dysfunction affecting learning 
and memory at least in part via primary effects on cofilin regulation and rod 
formation in sensitive hippocampal regions.  
 
Introduction 
Proteolytic cleavage of amyloid precursor protein (APP) by β- and γ-
secretases gives rise to Aβ peptides ranging in length from 39-43 amino acids 
(Glenner & Wong, 1984; Hardy, & Selkoe, 2002; Mattson, 2004; Price, et al., 
1995; Sisodia & Price, 1995; Tanzi, & Bertram, 2005).  Early onset familial AD is 
linked with high penetrance to mutations that lead to increased production of the 
most amyloidogenic species, Aβ1-42 (Chartier-Harlin et al., 1991; Goate et al., 
1991; Murrell et al., 1991; Price et al., 1995).  The “amyloid hypothesis” proposes 
that increasing cerebral accumulation of Aβ over years to decades exacerbates 
cognitive decline, neurodegeneration, and senile plaque deposition associated 
with AD. Elevated Aβ can result from mutations or allele expression patterns (or 
both) that enhance its production/aggregation or decrease its clearance/ 
degradation (Hardy & Selkoe, 2002).  
The concept that different isoforms and/or conformations of Aβ deliver 
independent signals to neurons is widely supported.  Although the term Aβ is 
used to describe a spectrum of peptide species, the effects of different Aβ 




& Bamburg, 2007; Heredia et al., 2006).  Emphasis has been placed recently on 
the characterization of small soluble oligomeric forms of Αβ, sometimes referred 
to as Aβ-derived diffusible ligands (ADDLs) (Kraaft and Klein, 2010).  ADDLs are 
toxic to cultured neurons at nanomolar concentrations (Lambert et al., 1998) and 
at 500 nM they prevent high frequency stimulation-induced long-term potentiation 
(LTP) measured from the dentate gyrus in acute hippocampal slices (Wang et al., 
2002). Furthermore, ADDLs have been linked to hippocampus-dependent 
temporal memory deficits in mice. Deletion of the BACE1 gene in Tg6799 mice, 
expressing mutant forms of human APP and presenilin-1, lowered the 
concentration of ADDLs to wild type levels and rescued temporal memory 
deficits, implying a direct role of Aβ formation in memory loss (Ohno et al., 2006; 
Kimura et al., 2010).  ADDLs bind to synaptic sites on cultured hippocampal 
neurons (Gong et al., 2003; Lacor et al., 2004) where they impair insulin receptor 
signaling (Zhao et al., 2008) and where stimulation by insulin prevents the 
pathogenic binding of ADDLs (De Felice et al., 2009). 
An even more potent synaptic-inhibitory preparation of Aβ containing 
SDS-stable dimers and trimers (Aβd/t) has been obtained from culture medium of 
a CHO cell line (7PA2) expressing a mutant human APP (Walsh et al., 2002).  
When used at their physiologically relevant (subnanomolar) concentrations to 
treat hippocampal slices, the Aβd/t fraction and a fraction of Aβ dimer obtained 
from postmortem human AD brain markedly inhibited the development of long-
term potentiation and enhanced long-term depression (LTD), electrophysiological 




Shankar et al., 2008). Single intracerebral ventricular (i.c.v.) infusions into adult 
rat brain of either gel filtered Aβd/t from 7PA2 cells or Aβ dimer from human AD 
brain caused transient memory and learning deficits (Walsh et al., 2002; Cleary 
et al., 2005; Townsend et al., 2006; Shankar et al., 2008; Freir et al., 2010).  
Infusion (i.c.v.) of Aβd/t into adult rat brain several hours after training inhibits 
synaptic remodeling that accompanies learning and memory consolidation by 
preventing a transient increase in the number of synapses in the dentate gyrus 
(Freir et al., 2010).  Although their mechanism is unknown, the SDS-stable Aβd/t 
or dimer fractions cause synaptic dysfunction at sub-nanomolar concentrations, 
which are 103- 104 fold lower than commonly used traditionally prepared 
oligomeric forms of synthetic Aβ, and 102-103 fold lower than concentrations of 
ADDLs.  In this regard it is significant that the presence of the SDS-stable Aβ 
dimer is strongly associated with Alzheimer-type dementia (McDonald et al., 
2010).    
In addition to the classical hallmarks of AD pathology, amyloid plaques 
and phospho-tau-containing neuropil threads and neurofibrillary tangles, 
histopathological structures involving actin and the actin-binding protein, cofilin, 
have been identified in AD brain (reviewed in Bamburg & Bloom, 2009).  Rod-
shaped arrays of cofilin-saturated actin bundles (cofilin-actin rods) are induced in 
cultured hippocampal neurons and organotypic hippocampal slice cultures in 
response to mitochondrial dysregulation (ATP-depletion) (Minamide et al., 2000; 
Huang et al., 2008; Davis et al., 2009; Bamburg et al., 2010), oxidative stress 




2000), extracellular ATP (Homma et al., 2008), overexpression of cofilin 
(Bernstein et al., 2006), and exposure to Aβ oligomers (Maloney et al., 2005; 
Davis et al., 2009), each of which is a potential mediator of synaptic loss 
observed in both familial and sporadic AD (reviewed in Ohm et al., 2007).  Rods 
contain actin and cofilin in a 1:1 complex (Minamide et al., 2010), they form in 
tandem arrays (striations) within neurites, and they serve as sites for 
accumulation of phosphorylated tau (Whiteman et al., 2009), suggesting that they 
may play a role in formation of striated neuropil threads, the major tau pathology 
in human AD brain (Velasco et al., 1998).  Cofilin-actin rods can grow to 
completely occlude the neurites in which they form (Minamide et al., 2000) and 
thus inhibit vesicular transport (Maloney et al., 2005; Jang et al., 2005) and 
cause microtubule loss (Minamide et al., 2000). Because an early indication of 
AD is blockage in axonal transport that leads to axonal swellings (reviewed in 
Stokin and Goldstein, 2006; Velasco et al., 1998) and synaptic loss (Davies et 
al., 1987), we investigated the ability of the physiologically relevant amounts of 
Aβd/t to induce cofilin activation (dephosphorylation) and rod formation in rat 
hippocampal neurons and organotypic slices.  The Aβd/t dose, time course, 
reversibility of Aβd/t rod formation, and the location of rods in the hippocampus, 
all suggest that cofilin-actin rods are likely mediators of Aβd/t in synaptic 







Materials and Methods 
Reagents 
All chemicals are reagent grade and were obtained from Sigma-Aldrich 
Co. and all tissue culture reagents were from Life Technologies (Invitrogen, 
Carlsbad, CA). Synthetic Aβ peptide (Aβ1-42) and a scrambled peptide with the 
Aβ1-42 amino acid composition were purchased from AnaSpec, Inc. (San Jose, 
CA).  Amyloid beta monomer and dimer/trimer fractions were prepared from the 
culture medium of CHO 7PA2 cells (Walsh et al., 2002) as previously described 
(Cleary et al., 2005; Shankar et al., 2007), and unless noted otherwise were used 
at 1x concentration (equivalent to their secreted concentration in the medium).  
Similar fractions obtained from culture medium of wild type CHO cells were used 
as controls.   
 
Culture treatments of dissociated neurons and slices 
Synthetic Aβ oligomer was made by solubilizing the peptide in 
hexafluoroisopropanol and drying in 10 μg aliquots.  Each 10 μg of synthetic Aβ1-
42 was solubilized in 10 μL of DMSO, diluted with 78.6 μL of sterile Ham’s F-12 
(to yield a 25 μM stock) and incubated 24 h at 4ºC (Dahlgren et al., 2002; Stine 
et al., 2003; Maloney et al., 2005).  Scrambled peptide was prepared identically 
and both scrambled peptide and synthetic Aβ1-42 oligomer were added to a final 
concentration of 1 μM.  The secreted Aβ fractions (monomer or d/t) or the 
corresponding fractions from control medium, were prepared as described 




ammonium acetate buffer. These were reconstituted to 5X or 10X in culture 
medium and diluted with culture medium to achieve the desired final 
concentrations.  Di-tyrosine oxidized Aβ1-42 dimer was prepared from synthetic 
human Aβ1-42 by incubation in the presence of Cu2+ and hydrogen peroxide as 
previously described (Atwood et al., 2004; Barnham et al., 2004; Smith et al., 
2007). The oxidized tyrosine dimer Aβ was assayed for rod inducing ability in 
dissociated neuronal cultures. Treated cultures were placed the incubator for 24-
48 h before further treatment or experimentation.  
 
Animals 
Timed pregnant Sprague Dawley rats were obtained from Harlan 
(Indianapolis, IN).  E18 fetal rat hippocampal neurons were obtained from timed-
pregnant dams and were frozen for future culture work as per published methods 
(Mattson and Kater, 1988).  Pups were sacrificed on postnatal days 6-10 for slice 
preparation.  Animal studies were performed according to the National Research 
Council’s guide for care and use of laboratory animals using protocols approved 
by the Institutional Animal Care and Use Committee. 
 
Dissociated hippocampal neurons and organotypic slice cultures 
Primary hippocampal neurons from E18 rat embryos were prepared and 
cultured essentially as described (Minamide et al., 2000).  Hippocampal slice 
cultures were prepared from P6-P10 Sprague Dawley rat pups also essentially 




into filter sterilized ice-cold (4ºC) Gey’s Balanced Salt Solution plus 4% glucose, 
then sliced to a thickness of 400 μm on a McIlwain tissue chopper.  Although for 
some slices we maintained some entorhinal cortex along with the hippocampus 
to minimize the degeneration of the perforant pathway (Davis et al., 2009), and it 
made no difference in the results.  For most slice treatments, 3-6 slices were 
arranged onto 0.4 μm Transwell® Polyester membranes inserted into 6 well 
culture plates (Corning Costar® 3450, Lowell, MA). Beneath the membrane was 
added 1.7 mL of filter sterilized slice culture medium (50 mL horse serum, 50 mL 
Hank’s Balanced Salt Solution (HBSS), 100 mL Minimal Essential Medium 
(MEM), 500 μL 1.25 mM L-glutamine, 4 mL 25% glucose, 1 mL 10,000 U/mL 
Penicillin-Streptomycin).  MEM is 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic 
acid (HEPES) and bicarbonate buffered.  Slice culture medium was aspirated 
and replaced with 1.5 mL of fresh medium on day 3 and every 2-3 days 
thereafter or with treatment medium as required.  For all experiments slices were 
cultured for about 10 days in a 95% air/5%CO2 incubator at 35oC.   
 Hippocampal slices were also cultured on coverslips.  Slices (1 or 2) were 
placed onto 12 x 22 mm coverslips, and embedded in 20 μL of chicken plasma 
(Cocalico Biologicals, Inc., Reamstown, PA) containing 6 μL of freshly added 
thrombin (150 NIH units/mL in water; MP Biomedicals, Inc.).  Slides were placed 
hippocampal side up on flat bottom test tubes (Nunclon Delta Tubes, Nalge 
Nunc, Rochester, NY) and 700 μL slice culture medium was added.  Tubes were 
placed at a 5o angle in a roller incubator (10 revolutions per hour) at 35oC and 






Lyophilized gel filtration fractions of 7PA2 and control culture medium, and 
synthetic Aβ oligomer preparations were resuspended in 10 µL of 2x sample 
buffer.  For Western blots, samples were electrophoresed on 10–20% acrylamide 
gradient Tris-Tricine Ready Gels (Bio-Rad, Hercules, CA).  Proteins were 
transferred onto nitrocellulose (0.1 µm; Whatman, Dassel, Germany), the 
membrane heated to boiling for 10 min in PBS and blocked at room temperature 
in 1% BSA, 2% goat serum in 20 mM Tris-HCl, pH 7.4, containing 150 mM NaCl 
(TBS) for 30 min.  The primary antibody used was the Aβ  monoclonal antibody 
6E10 (Covance, Dedham, MA; 1:1000 in TBS plus 0.05% Tween-20 (TBST)), 
incubated overnight at 4o C.   
Approximately 25-33% of a slice containing the dentate gyrus and mossy 
fiber tract region was microdissected and prepared separately from the 
remainder of the slice from untreated, Aβd/t-treated or synthetic Aβ-treated 
cultured hippocampal slices.  These were placed in 10 μL of 2X sample 
preparation buffer (200 mM Tris-HCl pH 6.8, 2% SDS, 40% glycerol, 2% 2-
mercaptoethanol, 0.04% Bromophenol Blue), heated to boiling for 3 min, and 
cooled on ice.  Adequate cofilin and phospho-cofilin immunostaining for 
quantification could be detected on western blots with about 25% of an 
organotypic slice. Thus, we combined 2-3 dentate gyrus/mossy fiber tract pieces 
and loaded about 30% of the sample and combined two of the remaining regions 




Tris/Glycine SDS-gel (Laemmli et al., 1970).  Proteins were transferred to PVDF 
membrane, blocked with 5% milk in TBS and cofilin and phospho-ADF/cofilin 
were detected using a cofilin monoclonal antibody MAb22 (Abe et al., 1989; 1-2 
ng/μL in TBST) and affinity purified rabbit antibody 4321 to phospho-ADF/cofilin 
(Meberg et al., 1998; 0.1 ng/μL).  Primary antibodies were incubated overnight at 
4o C.  
Secondary antibodies (goat anti-mouse or goat anti-rabbit) conjugated to 
DyLight 680 or DyLight 800 (1:15,000; Thermo Scientific, Rockford, IL) were 
added and incubated for 45 min at room temperature.  Blots were washed with 
TBST and bound antibody was visualized with a LI-COR Odyssey Infrared 
Imaging System.  Band intensities were quantified using TotalLab software 
(Nonlinear Dynamics, Newcastle upon Tyne, UK).  For quantitative ratio imaging 
of total cofilin/ phospho-cofilin, readings were obtained from the same sample on 
the same blot at the two wavelengths for detection and thus did not require 
normalization for gel loading. For several samples we also loaded half the 
amount used for quantification to determine that we were within the linear range 
of detection (signal intensity decreased by 50% when identical imaging 
parameters were used).   
 Aβ was quantified in 7PA2 cell culture medium, combined gel filtration 
fractions of the 7PA2 medium, synthetic Aβ oligomer preparations, and tyrosine 
dimers using a dot blot assay with synthetic human β-amyloid peptide (Aβ1-42) as 
a standard. Blots were on nitrocellulose (0.1 μm). Once samples were applied, 




then Aβ was detected with 6E10 antibody and spots quantified as described 
above for Western blots.   
 
Adenoviral-mediated gene expression 
Adenoviruses for expressing slingshot phosphatase 1L (SSH1L), 
constitutively active LIM kinase (LIMKT508EE), a dominant negative LIM kinase 
(D470A) and human cofilin-EGFP have all been described previously (Dawe et 
al., 2003; Soosairajah et al., 2005; Garvalov et al., 2007).  These were used at a 
multiplicity of infection (m.o.i.) of 100-300 for infecting dissociated neurons.  For 
infection of organotypic slices, about 107 adenoviral particles were added directly 
to the slice culture medium on day 7 and the cultures were returned to the 
incubator until treated with Aβd/t or control material on day 8 and fixed for 
analysis on day 10.  Slices cultured on membranes were infected with 
adenovirus by placing a drop of the adenovirus directly on the slice and adding 
any excess virus to the culture medium below the slice.  One to two hours later 
the liquid on top of the slice was removed and mixed with the culture medium 
below the slice. This method gave a higher efficiency of infection than if the virus 
was only added to the medium below the slice 
 
Fixation and immunostaining 
Dissociated neurons and slices were fixed for 4 h at room temperature in 
4% paraformaldehyde in either cytoskeletal buffer (CBS; 10 mM MES pH 6.1, 




PBS adjusted to pH 7.0, with no apparent differences between buffers.  Slices 
were methanol (-20oC) permeabilized for 10 min and blocked in 2% goat 
serum/1% bovine serum albumin in Tris-buffered saline before immunostaining.  
Primary antibodies include: affinity purified rabbit 1439 IgG to chick ADF (2 
ng/μL), which cross-reacts with mammalian ADF and cofilin (Shaw et al., 2004), 
protein A purified monoclonal mouse anti-cofilin (MAb22; 10 ng/μL IgG) (Abe et 
al., 1989), affinity purified rabbit IgG to the phosphorylated peptide of chick ADF 
(rabbit 4321; 1 ng/μL) (Meberg et al., 1998), and mouse monoclonal antibody to 
actin (clone C4; ICN Biomedicals, Inc., Costa Mesa, CA).  Secondary antibodies, 
all used at 1:450, include fluorescein goat anti-rabbit and goat anti-mouse and 
Texas-Red goat anti-rabbit and goat anti-mouse (Molecular Probes, Eugene, 
OR).  DAPI (4’-6-Diamidino-2-phenylindole) or Hoechst 33342 were used to stain 
DNA.  After blocking and staining, slices on membrane were cut out and 
mounted on 22 x 22 mm cover glasses with ProLong Gold Antifade (Molecular 
Probes). 
 
Microscopy and Image analysis 
An Olympus IX81 microscope equipped with an ASI piezo stage (Applied 
Scientific Instrumentation, Eugene, OR), CSU22 spinning disk confocal head 
(Yokogawa Instruments, Japan), 440 nm, 473 nm and 561 nm diode lasers, and 
a 1Kx1K Cascade II EMCCD Camera (Roper Scientific, Tucson, AZ), all 
integrated and operated by SlideBook software (Intelligent Imaging Innovations, 




The objectives used include 4x Fluorite (0.13 NA), UAPO40X/340W-DIC (1.35 
NA), or PlanAPO 60x (1.42 NA). 
 Phase-contrast and non-confocal fluorescence micrographs were obtained 
on a Nikon Diaphot using 4x (0.13 NA), 10x (0.25 NA), 20x (0.75 NA) air 
objectives or 40x (1.3 NA), 60x (1.4 NA), 100x (1.4 NA) oil.  For experiments in 
which we localized active cofilin across an entire slice, fixed slices were 
immunostained for phospho-ADF/cofilin (rabbit antibody 4321) and total cofilin 
(mouse MAb22), stained with different fluorescently tagged secondary 
antibodies, and imaged using the 4x objective, which allowed capture of most of 
the hippocampal area in one field.  The two images were overlaid (total 
cofilin/phospho-cofilin) and a hot scale applied to the ratio image such that the 
hottest colors correspond to the regions of most active (dephosphorylated) 
cofilin. 
 MetaMorph v7.03 software (MDS Analytical Technologies, Toronto, 
Canada) was used for all digital processing.  Following time-lapse imaging the 
slice was scanned for rod formation.  All experiments were repeated a minimum 
of three times.  To ascertain the regional distribution of rods, the total number of 
rods per field was counted using a 60x oil objective and data from multiple slices 
were combined onto a schematic of the hippocampus as described previously 








Statistical analyses were done with either MATLAB or SPSS v13.  All 
significance values are at p<0.05 and all error bars are standard deviations 
unless otherwise stated.  Any post hoc tests are reported. 
 
Results 
Amyloid beta dimer/trimer is a potent inducer of cofilin-actin rods 
SDS-PAGE and Western blot analysis of the amyloid beta (Aβ) 
immunoreactive components in fractions of 7PA2 culture medium demonstrated 
separation of monomer from a fraction enriched in dimer/trimer (Aβd/t) (fraction 
12-13, Figure 2.1A).  Treatment of cultured dissociated hippocampal neurons 
with the Aβd/t fraction at 1X concentration (1X = the equivalent concentration 
produced in the CHO 7PA2 cell culture medium) induced cofilin-actin rods in 
many neurons, similar to treatment with 1μM of synthetic Aβ oligomers (Figure 
2.2).  Significant rod induction did not occur in neurons treated with either the Aβ 
monomer fraction (e.g. fraction 15, Figure 2.1A) or fraction 12-13 prepared from 
medium of wild type CHO cells (non-conditioned (NC) medium).  Incubation of 
Aβd/t or synthetic Aβ oligomer with an anti-Aβ monoclonal antibody (6E10) for 15 
min prior to neuronal treatment reduced rod formation to control levels, strongly 















Figure 2.1: Preparation and quantification of Aβd/t. (A) Aβ Western 
blot (6E10 antibody) of gel filtration fractions from a single Superdex75 (10/30 
HR) column run at a flow rate of 0.5 mL/min and loaded with 1 mL of a 10X 
concentrate of 7PA2 cell conditioned (16 h) DMEM medium (Cleary et al., 2005; 
Shankar et al., 2007). (B, C) Dot blot standard curve for quantification of Aβ 















Figure 2.2: Aβd/t fraction from 7PA2 cells, but not monomer, induces rods 
in dissociated hippocampal neurons. Analysis by fluorescence microscopy of 
dissociated neurons treated with vehicle (control), scrambled Aβ peptide (1 μM), 
or nonconditioned (NC media, d/t equivalent fraction), as well as with the 
monomer and d/t fractions from 7PA2 cell culture medium and synthetic Aβ 
oligomers (Aβsyn). (A) Cofilin immunostained fluorescence images of 
hippocampal neurons showing representative responses with cofilin-actin rods 
formed 24 h after treatment with Aβd/t- and Aβsyn treated neurons. Pretreatment 
of the Aβ-fractions with an antibody (6E10) to Aβ eliminates their rod-inducing 
effects. Bars = 10 μm. (B) Quantification of the rod forming response showing the 
neutralizing effects of the 6E10 antibody and the non-significant changes in rod 
formation by Aβ monomer. (* = p < 0.05 compared to control; # not significantly 




that is responsible for inducing rods.  The percentage of neurons with rods was 
quantified from each of the cultures treated with fractionated NC medium, 
monomeric Aβ, the Aβd/t fraction, and synthetic Aβ oligomer (Figure 2.2B).  Only 
the Aβd/t fraction and synthetic Aβ oligomers induced a significant (p<0.01) 
increase in the percentage of neurons with rods above untreated (or synthetic 
scrambled peptide-treated) controls.  Pretreatment with 6E10 antibody eliminated 
this increase.   Furthermore, the percentage of Aβd/t-treated neurons forming 
rods (about 30%) represents a significant (p<0.05) increase versus treatment 
with the 1 μM synthetic Aβ oligomers (18%).  
 The total concentration of Aβ species in 7PA2 conditioned medium was 
previously reported to be 6.4 ng/mL (1.4 nM) based on ELISA (Cleary et al., 
2005).  However, oligomers of human Aβ are inefficiently measured by ELISA 
(Stenh et al., 2005).  Therefore we measured the total Aβ concentration in 
several batches of 7PA2 medium using a dot blot assay and obtained the value 
of 8.3 ± 0.8 ng/mL (s.d.) (Figure 2.1).  The amount of Aβd/t and Aβm in 1X 
fractions were also determined directly from dot blot assays to be approximately 
1.1 ng/mL and 3.6 ng/mL, respectively, equal to about 250 pM and 800 pM 
based on monomer content (there was some variability from preparation to 
preparation depending on the fractions pooled).  Our Aβd/t concentration values 
are very close to those estimated from the Aβd/t immunostaining on Western 
blots after epitope exposure by boiling the membrane (Cleary et al., 2005), and 




 We next compared the Aβd/t fraction to the synthetic Aβ oligomer for their 
dose-response in rod-induction.  The gel filtration fractions elute in 50 mM 
ammonium acetate, pH 8.5 and are freeze dried to remove most of the volatile 
buffer. However, when reconstituted they cannot be used above a 2.5X 
concentration because of increased cell death (release of LDH, data not shown).  
However, neurons could be treated with these fractions from 0.1X to 2X without 
any significant cell loss over 48 h.  One control for Aβd/t is an identically treated 
volume of culture medium from wild type CHO cells.  As shown in Fig. 2.3A, the 
half maximal response in terms of numbers of neurons forming rods is achieved 
with about 0.4X Aβd/t (∼100 pM) and  ∼0.7 μM synthetic Aβ oligomers, about a 
7000 fold difference between the half-maximal responses.  This value compares 
favorably with a more conservative 4000 fold difference obtained with the single 
point comparison at 1X concentration (250 pM Aβd/t versus 1 μM synthetic 
oligomer), which gives near maximal rod response for each preparation.  
Furthermore, the maximum percentage of cells with rods is about 10% greater 
with the Aβd/t than with the synthetic Aβ oligomers at all but the lowest 
concentrations used.   
 When synthetic human Aβ was incubated under conditions that generate a 
tyrosine oxidized dimer, the concentration that was required to induce rods 
decreased dramatically.  The oxidized dimer had a maximum rod-inducing 
activity at ~2 nM (10 ng/mL), suggesting it is the presence of the SDS-stable 
tyrosine oxidized Aβ dimer in a low-n state that is largely responsible for the 









Figure 2.3: Percent of neurons in dissociated hippocampal cultures 
containing rods as a function of Aβ form, concentration and time of 
treatment. (A) Dose-response curves for Aβsyn and Aβd/t versus control. The 
concentrations are expressed in terms of the 7PA2 CHO cell secreted 
concentration of Aβd/t (1X), which was used at 0.1, 0.5 and 2X this value. For the 
synthetic Aβ oligomers, the 1X value equals 1.0 μM. (B) Following treatment with 
1X amounts of Aβd/t or Aβ synthetic oligomer, neurons were fixed at the times 
shown and the percent of neurons with rods was quantified. By 2 h the percent of 
neurons forming rods in response to Aβd/t was significant (*) over controls 
(p<0.05). The Aβsyn-treated neurons required 6 h to reach significance over 
controls. Significance (# = p<0.05) in the differences between the two Aβ species 










Time course of rod formation 
We previously observed that the percentage of neurons forming rods in 
response to 1 μM synthetic Aβ oligomers did not increase significantly over 
untreated samples until 6 h after addition (Maloney et al., 2005).  Because the 
Aβd/t fraction is more active in rod induction than synthetic Aβ, we directly 
compared the time course between these two treatments.  The 1X Aβd/t fraction 
induces a measurable but not significant increase in rods over untreated controls 
by 1 h becoming significant (p<0.05) by 2 h, at which time about 25% of the 
maximum response is obtained (Figure 2.3B).  Although 1 μM synthetic Aβ 
oligomer increased rod induction over the untreated controls by 4 h, the increase 
did not become significant until 6 h as previously observed (Maloney et al., 
2005).  By 8 h significantly (p<0.05) more Aβd/t-treated neurons have rods than 
neurons treated with synthetic Aβ oligomer and this difference is maintained 
through 24 h.  
 
Stability of the added Aβd/t fraction 
To determine if the Aβd/t fraction added to the cultured organotypic slices 
underwent a change in concentration or altered its SDS-stable dimer/trimer form 
during the incubation, we removed culture medium at the end of experiments (48 
h) and human Aβ was immunoprecipitated and reanalyzed by SDS-PAGE 











Figure 2.4: The Aβd/t fraction remains stable for 48 h when incubated with 
neurons. Immunoprecipitates from 7PA2 medium (IP positive controls 
on left) and from neuronal culture medium 48 h after treatment with Aβd/t, the 
equivalent fraction from NC medium, or the monomer fraction. The load volume 
on the right is equivalent to 0.4 mL of starting 7PA2 medium and the dimer/trimer 
bands are slightly less than what is contained in the 0.5 mL of starting medium 











Regional analysis of rod formation in slices 
The numbers of rods in fields taken from multiple organotypic 
hippocampal slices treated 48 h with 1X Aβd/t fraction or with control treatments 
used above were mapped onto a matrix grid of the hippocampus using fiduciary 
points to stretch and fit multiple slice data onto a single summary map as 
previous described (Davis et al., 2009).  Similar to the localization of rods in 
response to synthetic Aβ (Davis et al., 2009), a treatment also repeated here 
(data not shown), the Aβd/t-induced rods were mainly localized to the 
polymorphic hilar region of the dentate gyrus and along the mossy fiber tract into 
the CA3 region (Figure 2.5).  Furthermore, the numbers of rods per grid square is 
on average 2-3 fold higher than for the comparable region of the slices treated 
with synthetic Aβ oligomer (not shown, but compare numbers on hot scale in 
Figure 2.5A with the top scale of 15 rods per square previously published for 
synthetic Aβ-treated slices (Davis et al., 2009)).  Rod numbers in slices treated 
with the gel filtration fraction of NC CHO cell medium were not significantly 
different from untreated controls and thus data from these slices were combined 
to make the control panel (Figure 2.5A).  Similar to what was observed in 
dissociated neurons (Figure 2.2B), pretreatment of Aβd/t with 6E10 antibody 






Figure 2.5. Numbers of rods induced by Aβd/t are highest in neurons within 
the dentate gyrus and mossy fiber tract in organotypic hippocampal slices. 
(A) Organotypic hippocampal slices were cultured for at least 8-10 days and 
were left untreated or treated with 1X Aβd/t, the same amount of the equivalent 
NC medium fraction, or scrambled Aβ peptide. After 48 h, slices were fixed and 
immunostained for cofilin and DNA (DAPI), and rods were quantified by counting 
with a 60x objective. Rod mapping from multiple slices onto a matrix grid of the 
hippocampus was performed as previously described using fiduciary markers 
from the stained nuclei layers to align hippocampal regions (Davis et al., 2009). 
There were no differences detected in rod numbers or distribution between the 
untreated slices and those treated with NC medium or scrambled peptide and 
these were all combined to give the control panel. Rods induced by the Aβd/t 
were heavily concentrated over the dentate gyrus and mossy fiber tract. (n = 18 
for control slices and n = 12 for Aβd/t treated). (B) Rod quantification averaged 
per field over different regions of the slices. Each field acquired with the 60x 
objective has about 6-7 matrix grid squares. The only regions of significance (# = 





Dose response curves for rod induction in organotypic slices 
We compared the dose-response curves for rod formation in response to 
Aβd/t and synthetic Aβ oligomers in organotypic slice cultures by quantifying rods 
per field (Figure 2.6A).  It should be noted that one field encompasses the 
equivalent of about 6-7 matrix grid squares and that rod counts were averaged 
over the entire slice.  Surprisingly, slices treated with the Aβd/t fraction at 0.1X 
(estimated to be 25 pM) have a significant (p<0.05) increase in rods per field over 
controls, equivalent to the numbers of rods per field induced by 500 nM synthetic 
Aβ oligomer.  The curves are very similar to the dose-response measured in 
dissociated neuronal cultures and quantified as percent of neurons with rods 
(Figure 2.3).   
 
Rods induced by Aβd/t are reversible 
To test if rods induced in organotypic slices by Aβd/t are reversible, the 
Aβd/t was washed out 24 h after treatment and slices were allowed to recover for 
24 h in control medium.  As previously demonstrated for rods induced by 
synthetic Aβ (Davis et al., 2009), the majority of rods induced by 1X Aβd/t 
disappear 24 h after washout (Figure 2.6B). 
 
Cofilin dephosphorylation is induced by Aβd/t 
We evaluated the changes in cofilin phosphorylation levels in response to 
Aβd/t-treatment of organotypic slices using both Western blotting and 





Figure 2.6. Dose-response curve for rod formation in organotypic 
hippocampal slices and reversibility of Aβd/t-induced rods. (A) The same 
concentrations of Aβd/t and synthetic oligomer used in Figure 2.3A were applied 
to organotypic hippocampal slices. After 48 h, slices were fixed and rods 
immunostained and quantified per field averaged across the entire slice. The 
curves obtained are very similar to those in dissociated neurons but the 
measured parameters are different (average rods per field measured here vs. 
percent neurons with rods in Figure 2.3A). (B) Rods formed in response to Aβd/t 
in hippocampal slices reached their maximum value by 24 h (see Figure 2.3B). 
To determine rod reversibility, some of the slices were washed free of the Aβd/t 
and allowed to incubate another 24 h, whereas others had the Aβd/t present 
continuously. Controls were treated with the NC medium for 48 h or were left 
untreated (no difference). As previously shown for the rods induced by synthetic 










Figure 2.7. Aβd/t induces cofilin dephosphorylation (activation) within the 
hippocampal region where rods are most abundant. (A, B) Western blots of 
extracts from whole slices (A) and microdissected slice regions (B) from either 
untreated (controls) or slices treated with Aβsyn or Aβd/t. Blots were stained for 
GAPDH (loading control), total cofilin (MAb22 antibody) and phospho-ADF/cofilin 
(rabbit antibody). The ratio of the immunostaining for total cofilin/phospho-cofilin 
showed that in whole slices (A) there was a slight (1.08 fold) increase in cofilin 
dephosphorylation following Aβsyn treatment and a larger (1.35 fold) increase in 
slices treated with the Aβd/t (n = 3 slices). (B) In the microdissected regions 
containing the dentate gyrus and mossy fiber tract the Aβsyn treatment increased 
cofilin dephosphorylation by 1.28 fold and the Aβd/t increased it by 2.04 fold. The 
remainder of the slice regions (other) showed no significant change in phospho-
cofilin levels. (C) Ratio imaging of the total cofilin/phospho-ADF/cofilin 
immunostained slices also show a time dependent enhanced cofilin 
dephosphorylation that is localized over the dentate gyrus and mossy fiber tract 
(shown in the images here) but not elsewhere in the slices. Maximum ratio 
(white in hot scale) is set at 2. At this low magnification, only the largest of the 







The phospho-cofilin antibody also detects phospho-ADF equally well but ADF is 
expressed at only about 20% of the level of cofilin in the rat brain and phospho-
ADF declines similarly to phospho-cofilin (Figure 2.7B).  Immunoblots of whole 
slices show a slight decline in phospho-ADF/cofilin when treated with 1 μM 
synthetic Aβ oligomer and a greater decline when treated with 1X Aβd/t (Figure 
2.7A) as indicated by the increased total cofilin/phospho-cofilin ratio.  However, 
when regions of the hippocampus were micro-dissected for immunoblotting, 
larger changes in the ratio are observed in extracts from the dentate gyrus than 
from the remainder of slice (Figure 2.7B) and Aβd/t-treatment gave the greater 
rod-inducing response in this region.  Similar conclusions are reached by 
observing the fluorescence ratio images of total cofilin/phospho-ADF/cofilin 
staining of slices at 1, 8 and 24 h after treatment (Figure 2.7C).  The greatest 
changes were observed in the dentate gyrus shown in Figure 2.5C, where there 
was no quantifiable difference between the 0 (not shown) and 1 h time point, but 
a significant increase in the ratio (about 50% of maximum change) was observed 
by 8 h, similar to the time course for rod formation observed in Figure 2.3B.   
 Rods are not very apparent in the low magnification images used for slice 
ratio imaging (Figure 5C), but become apparent when viewed with a 60x 
objective, even in single confocal sections (Figure 2.8A).  However, the rod 
distribution and abundance within the dentate gyrus are more impressive when 
the confocal image stack is deconvolved and the lowest 20% intensity of 
immunstaining is removed by resetting the low threshold on an image histogram 





Figure 2.8. Three-dimensional reconstruction of cofilin-stained rods 
in deconvolved confocal image stacks from organotypic slices. Treatment 
of organotypic slices with Aβd/t results in a profound increase in cofilin 
immunostained rods in the dentate gyrus/mossy fiber tract (DG/MFT) and a 
global change in cofilin distribution in cells in this region. (A) Single focal plane of 
non-rod-forming region near the CA3 compared to a rod hot spot in the dentate 
gyrus. Rods are evident in this single plane. (B) Three dimensional stack of 
planes from a cofilin stained control and Aβd/t-treated slice. Deconvolution of the 
confocal image stacks and thresholding the image by removing the lowest 20% 
of signal (lower panels) provides striking evidence of rod formation in this region. 






the 3D reconstruction of the image stack from control slices whereas rods are 
abundant throughout the Aβd/t-treated slice.  
 
Modulating cofilin phosphorylation alters rod formation and response to Aβ 
oligomers 
Since rod formation correlates well with cofilin dephosphorylation, we 
examined the effects of enhancing or inhibiting cofilin dephosphorylation on rod 
formation in untreated dissociated neuronal cultures or those treated with 
synthetic Aβ oligomer.  Adenoviral-mediated expression of the cofilin 
phosphatases, either slingshot (SSH1L) or chronophin (CIN), but not their 
inactive forms, increases rod formation in the absence of any other rod-inducing 
treatment whereas the inactive form of slingshot (C393S) appears to act in a 
dominant negative manner by reducing rod formation in Aβd/t-treated cells 
(Figure 2.9A).  Fluorescent protein co-expression allowed us to identify the 
infected cells and score these independently from the uninfected cells in the 
same culture.  Greater than 15% of neurons overexpressing SSH1L formed rods, 
the most dramatic effect observed, whereas about 8% of neurons expressing 
CIN formed rods.  Treating neurons expressing these cofilin phosphatases with 
Aβ significantly (p<0.05) enhanced rod formation above the levels induced by the 
Aβ-treatment alone to a maximum of 38% for the SSH-1L expressing neurons; 
expressing the dominant negative form of SSH1L kept the number of neurons 






Figure 2.9. Upstream regulators of cofilin phosphorylation impact the 
ability of Aβd/t to induce rods. Rod formation was quantified in (A) dissociated 
hippocampal neuronal cultures or (B) organotypic hippocampal slices that were 
uninfected (Con), infected with control adenovirus expressing GFP (GFP) or with 
adenoviruses expressing various upstream regulators of cofilin phosphorylation. 
All viruses coexpressed a fluorescent protein marker and only neurons 
expressing the marker were scored in the dissociated cultures. In slices, infection 
rates were approximately 70% (see Figure 2.10) and rods per field were 
quantified (it was not possible in slices to count rods only within infected 
neurons). Neurons or slices were infected 24 h prior to treatment with Aβd/t and 
were fixed and analyzed for rod formation 48 h after Aβd/t addition. Treatments 
that enhanced cofilin dephosphorylation (the active phosphatases SSH-1L WT 
and CIN WT) in the dissociated cultures enhanced rod formation with or without 
Aβd/t treatment (* = significant difference from untreated or GFP controls at 
p<0.05; # significantly different from Aβd/t treated controls, p<0.05). Treatments 
that inhibited cofilin dephosphorylation (LIMK1 WT and the active 
LIMK1T508EE), inhibited rod formation in response to Aβd/t in both dissociated 




Expression of a dominant negative LIM kinase, the major cofilin kinase, 
did not alter rod formation when expressed on its own, however its presence 
enhanced the percent of neurons forming rods in response to Aβd/t, although the 
difference (from 19-20% to 26%) is not significant at p<0.05.  The opposite effect 
was observed upon expression of the wild type or constitutively active form of 
LIMK1 (LIMKEE508).  LIMK1 expression reduced the percent of neurons forming 
Aβ-induced rods by about 50% for wild type and over 75% for the constitutively 
active LIMKEE508 and these values are significant at p<0.05 (Figure 2.9A).   
 A similar series of experiments were done using organotypic slices (Figure 
2.9B).  To first estimate the efficiency of transgene expression in the cells of 
organotypic slices by adenoviral infection, we examined slices at high 
magnification after adenoviral-mediated expression of a fluorescent protein and 
staining of nuclei with DAPI.  We quantified the number of nuclei with 
surrounding fluorescent protein expression (Figure 2.10) and determined a >70% 
infection efficiency when we used 107 infectious particles/slice (based upon a 
titer of infectious particles per mL obtained by expression of the viral E2b gene in 
infected cells; Minamide et al., 2003).  In organotypic slices, expression of 
SSH1L or CIN alone did not significantly increase rod formation (quantified as 
rods per field using the 60x objective) over controls.  In addition, we did not 
observe a rod response to Aβd/t in infected slices that was greater than for Aβd/t-
treated controls with any viral-mediated protein expression.  However, in slices 
infected with virus for expressing LIMK wt and LIMK508EE, the average rod 









Figure 2.10. (A) Low power images of a hippocampal organotypic slice 
stained with DAPI, immunostained for cofilin, and imaged for GFP-expression 
after infection with adenovirus expressing GFP behind a CMV promoter. (B) 
Comparison of infected cells in organotypic slices, measured by the numbers of 
cells showing GFP fluorescence around a DAPI stained nucleus (from either 
GFP control virus or DNLIMK1 AdTrack virus). Between 70-75% of the cells so 
examined were positive for GFP. (C) This panel was assembled to illustrate how 
we determined the percentage of infected cells. One region from a confocal 
plane of an image stack is shown. Staining for cofilin and actin are not important 
to the quantification of infectivity. The areas surrounding nuclei within this plane 
were examined for expression of GFP, which had to be above a threshold level 
for counting as positive. The nuclei were often above or below the optical section 
of the cell that contained the GFP and we had to move up and down single 
planes in Z series to obtain the most accurate counts. Many hundreds of nuclei 








we observed in dissociated cells (Figure 2.9A).  Taken together, these results 
suggest that cofilin dephosphorylation is both necessary and sufficient to induce 
rod formation in many neurons but that the total rod response is enhanced by 
Aβd/t-induced stress.  
 
Discussion 
Here we demonstrate that the dimer/trimer fraction of a naturally secreted 
form of Aβ is several thousand fold more active at inducing cofilin-actin rods than 
traditionally oligomerized samples of synthetic Aβ.  This level of activity for Aβd/t 
(250 pM) is within its estimated physiological concentrations based upon the 
amounts extracted from human AD brain (Shankar et al., 2008). Because the 
rod-inducing activity of the Aβd/t fraction is neutralized with an Aβ antibody, it is 
clearly Aβ that is the active rod-inducing component.  Furthermore, the Aβ 
monomer fraction does not induce rods (not significant above control), 
suggesting the dimer is the minimal active unit in promoting cofilin-actin rod 
formation.  At optimal concentrations of each, Aβd/t induces formation of rods in 
more hippocampal neurons than synthetic Aβ oligomers.  The Aβd/t also induces 
more rods per neuron based upon the rod counts per field taken across 
organotypic slices and mapped from multiple slices onto a hippocampal matrix 
using the methods we previously described (Davis et al., 2009). Because 
naturally secreted Aβ is cut from the APP by γ-secretase and has more variability 
in the peptide lengths that will comprise its mixture, it is certainly possible that 




inducing ability. However, the fact that the monomer fraction from secreted Aβ is 
not rod inducing, suggests that it is the process of oligomerization per se that 
differs for naturally produced and synthetic Aβ.  
  At the μM concentrations typically used to make oligomers, synthetic Aβ 
assembles rapidly (Hung et al., 2008) and virtually no SDS-stable dimer remains, 
although SDS-stable trimers and tetramers are present (e.g. Puzzo et al., 2008), 
suggesting that the dimer may be the major rod-inducing form.  .  Picomolar 
levels of the dimer-deficient synthetic Aβ oligomers enhance LTP, opposite to the 
effects of the dimer enriched fractions, but a finding that perhaps helps explain 
the normal physiological function of Aβ. It is not known what specific types of 
SDS-stable cross-linking occurs in the naturally secreted Aβ dimer, but it has 
been previously shown that tyrosine10 in the human Aβ sequence can undergo 
oxidation to form a di-tyrosine cross-link. Because this tyrosine residue is missing 
in rodent Aβ (phe in place of tyr), and rodent Aβ is deficient in oligomerization 
(Atwood et al., 2004; Marksteiner and Humpel, 2008), we investigated the 
biological activity of copper-peroxide oxidized Aβ that is di-tyrosine cross linked 
(Atwood et al., 2004; Barnham et al., 2004).  When synthetic human Aβ was 
incubated under conditions that generate a tyrosine oxidized dimer, the 
concentration that was required to induce rods decreased dramatically.  The 
oxidized dimer had a maximum rod-inducing activity at ~2 nM (10 ng/mL), 
suggesting it is the presence of the SDS-stable tyrosine oxidized Aβ dimer in a 
low-n state that is largely responsible for the rod-inducing potency of the secreted 




We found that the amount of the Aβd/t remained fairly constant in the 
medium over 3 d.  This is due in part to the fact that rodent Aβ does not 
oligomerize and hence the continued secretion of Aβ by the cultured neurons, 
which is even stimulated by the presence of the human Aβd/t (Chapter 1), does 
not contribute to the Aβd/t pool.  It also suggests that uptake of the Aβd/t either 
does not occur, or if it does occur it must be released again into the medium and 
not degraded by the cell. 
Enhancing cofilin activity by overexpressing either of the cofilin 
phosphatases slingshot or chronophin, enhanced rod formation in dissociated 
neurons in the absence of Aβ-treatment and expression of LIMK1 inhibited 
formation of rods even after Aβ-treatment.  This result was not unexpected since 
simple overexpression of cofilin, especially the non-phosphorylatable cofilin S3A 
mutant, enhances rod formation (Bernstein et al., 2006).  Expression of LIMK1 in 
organotypic slices reduced rod formation similar to its effect in dissociated 
neurons, but we did not see a significant increase in rods due to expression of 
either cofilin phosphatase.  Although we find about a 70% adenoviral infectivity 
rate of cells in the slices, it is quite likely that the non-neuronal cells infect better 
than the neurons and thus for some viruses the neuronal infectivity may be low 
enough that we would have difficulty in obtaining enough infected neurons to 
observe significant changes in rod formation.  
Single infusions into the adult rat brain of either Aβ dimer extracted from 
human AD brain or Aβd/t at the identical concentration used in our studies 




infusion, and completed within a 2 h maximum time frame (Cleary et al., 2005; 
Shankar et al., 2008).  Memory and learning deficits disappeared 24 h after the 
single infusions.  It is worthy to note in this regard that the Aβd/t fraction induces 
rods in a statistically significant number of neurons by 2 h after treatment (about 
25% of the maximal response) and that the Aβd/t rods are reversible, 
disappearing by 24 h after washout.  Thus, formation and disappearance of rods 
in cultured neurons and organotypic slices correlate well with the changes 
observed in memory and learning in whole animals exposed to a single infusion 
of Aβd/t.  
Nevertheless, there are some discrepancies in time of rod formation in 
response to Aβd/t treatment that do not correlate well with acute Aβd/t effects on 
slice electrophysiology.  Decreased long-term potentiation (LTP) and enhanced 
long-term depression (LTD) occur within 20 min of treating hippocampal slices in 
culture either with fractions containing Aβd/t (Townsend et al., 2006) or with Aβ 
dimer extracted from human AD brain (Shankar et al., 2008).  This response is 
more rapid than the 2 hours it takes to obtain a significant increase in rods in 
organotypic slices exposed to the Aβd/t fraction.  Rod formation has been 
observed to occur within 10 min in organotypic slice cultures responding to 
anoxia or ATP-depletion (Minamide et al., 2000; Davis et al., 2009).  However, 
the rate of Aβd/t induced rod formation in organotypic slices maintained in 
neurobasal/B27 medium may be significantly slower than in acute slices 
prepared for electrophysiology and maintained in artificial cerebrospinal fluid 




aCSF.  Insulin helps neurons resist the pathogenic changes in cytoskeletal 
organization induced by Aβ (De Felice et al., 2009).  Alternatively or in addition, 
we suspect that cofilin dephosphorylation and altered actin dynamics in response 
to Aβd/t is rapid and precedes rod formation in some compartments, such as 
dendritic spines.  Synaptic activity depends directly on cofilin function in 
regulating actin dynamics and may reflect early changes in plasticity (Shankar et 
al., 2007; Carlisle et al., 2008; Yuen & Yan, 2009; Gu et al., 2010).  Thus, the 
LTP/LTD response to Aβd/t could be independent of rod formation yet the result 
of a localized change in cofilin activity.  Significantly, wash out of Aβ after the 
electrophysiological changes have occurred did not result in any reversal in the 
altered LTP/LTD over 2 h.  This persistent effect could arise within the 
organotypic slice from relatively tight binding of the Aβd/t to specific sites for 
which some evidence does exist (Townsend et al., 2006; De Felice et al., 2009).  
Alternatively, rod formation may have occurred by the time washout was initiated 
and rods could be responsible for the lack of rapid recovery.  Rods sequester 
most of the cofilin (Minamide et al., 2000; Bernstein et al., 2006) needed to 
reestablish the balance in spine actin dynamics (Gu et al., 2010) and their 
formation would resist rapid recoveries of the spine cofilin pool.  
The most sensitive pool of neurons forming rods in response to both 
synthetic Aβ oligomers and Aβd/t are those within the polymorphic/hilar region of 
the dentate gyrus along the mossy fiber tract into the CA3.  The dentate gyrus is 
considered to play a central role in associative memory (Morris, 2006).  Its major 




one million excitatory entorhinal neurons from layer II.  These axons end 
preferentially within the outer two thirds of the superficial molecular layer, mainly 
on the apical dendrites of the granule cells, but also on dendrites of interneurons 
(Ohm, 2007).  Cholinergic neurons from the basal forebrain provide another 
important afferent input, and also synapse with neurons of the dentate gyrus 
inner molecular layer.  The CA3 pyramidal cells receive the granule cell output 
via the mossy fibers (granule cell axons) and aid in pattern completion 
(Nakazawa et al., 2002).  Because of its central role in associative memory, the 
dentate gyrus has been extensively studied in AD brain (Ohm, 2007).  There is 
an early loss of synapses (48% decrease in synapse to neuron ratio) before 
significant loss of neurons (Davies et al., 1987; Bertoni-Freddari et al., 1996; 
Scheff and Price, 2003).  Based upon the degree of immunofluorescence 
labeling for the synaptic marker synaptophysin, there is a direct correlation of 
synaptic loss during AD progression.  Early, mild and severe AD cases are 
accompanied by a decline in synaptophysin staining of about 25, 45 and 65%, 
respectively, in the outer and middle third of the molecular layer, with little to no 
loss in the inner third (Masliah et al., 1994).  Injection of single doses of Aβd/t-
containing medium into brains of adult rats also leads to defects in associative 
memory and to memory consolidation with a striking inhibition of the synaptic 
increases that occur during memory consolidation in the dentate gyrus (Freir et 
al., 2010).  Because cofilin-actin rod formation in response to Aβd/t is so 
prominent within the DG and mossy fiber tract, and the rods block transport and 




neuron (Minamide et al., 2000; Jang et al., 2005), they represent a likely 
mechanism to explain the synaptic loss associated with early stages of AD and 
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